DreamCIS

DreamCIS Net Margin

The Net Profit Margin of DreamCIS (223250.KQ) as of Oct 29, 2026 is 10.70 %. In the previous year, Net Profit Margin was 9.00 % — a change of 18.81% (higher).

Net Margin

10.70 %

YoY

18.81%

Last updated:

Net Profit Margin of DreamCIS is 2025 10.70 % . Net Profit Margin of DreamCIS was 2024 9.00 % . It decreases by 18.81% higher compared to the previous year.

DreamCIS's net margin stands at 10.7%, down from 12.3% several years earlier.

The DreamCIS Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
17.80 KRW
Jan 1, 2019
18.77 KRW
Jan 1, 2020
20.66 KRW
Jan 1, 2021
12.35 KRW
Jan 1, 2022
11.33 KRW
Jan 1, 2023
7.81 KRW
Jan 1, 2024
9.00 KRW
Jan 1, 2025
10.70 KRW
The DreamCIS Net Margin history
YEARNet MarginYoY
10.70 %+18.81%
9.00 %+15.19%
7.81 %-31.04%
11.33 %-8.20%
12.35 %-40.25%
20.66 %+10.06%
18.77 %+5.48%
17.80 %-353.66%
-7.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DreamCIS Stock analysis

What does DreamCIS do? DreamCIS Inc. is a company based in Seoul, South Korea, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company went public on May 22, 2020, with its stock listed under the ticker 223250.KQ and ISIN KR7223250002. DreamCIS Inc. provides clinical online information and consultation services, focusing on regulatory post-marketing surveillance (rPMS), clinical trials, and non-interventional studies (NIS). The company serves both domestic and international markets, offering its services to clients seeking support in clinical research and regulatory compliance. Its headquarters are located in Seoul, South Korea. The company's website is http://www.dreamcis.com/, which serves as a primary source for further information about its services and operations. DreamCIS Inc. does not provide detailed information about its founding year, specific leadership, or financial figures beyond its IPO date, and no acquisitions or additional product names are mentioned in the provided data. The company's services are primarily aimed at facilitating clinical research and ensuring adherence to regulatory standards in the life sciences sector. DreamCIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DreamCIS stock

Net Profit Margin of DreamCIS is 10.70 % in 2025.

Net Profit Margin of DreamCIS changed from 9.00 % to 10.70 %, representing a 18.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin DreamCIS since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's DreamCIS with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — DreamCIS

All Key Metrics — DreamCIS